Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/1/24 18:00 | 3/28/24 | AVXL | Health | BioPrd | Biological Products, (No Diag | Missling Christopher U | NY | DO | P,CEO | S.d | -375 | 5.11 | 0 | -73 | -6 | 1,250 | D | ||||||||||||||
6/30/23 20:00 | 6/28/23 | AVXL | Health | BioPrd | Biological Products, (No Diag | Missling Christopher U | NY | DO | P,CEO | S.d | -2,139 | 7.98 | 0 | -268 | -18 | 1,250 | D | ||||||||||||||
5/27/22 20:30 | 5/25/22 | AVXL | Health | BioPrd | Biological Products, (No Diag | Skarpelos Athanasios | NY | D | S.d | -453 | 9.06 | 0 | -50 | -4 | 1,306 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |